ArticleOsteoarthritis and cartilage open2026
Deep learning-based effusion-synovitis volume measured on MRI is associated with osteoarthritis progression: A longitudinal analysis of data from the osteoarthritis initiative.
Article in Osteoarthritis and cartilage open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Objective: To investigate whether the 48-month change in effusion-synovitis volume (ΔESV) is associated with concurrent knee osteoarthritis progression, and to compare these associations with those of semiquantitative change in effusion-synovitis using the MRI Osteoarthritis Knee Score (ΔMOAKS). Design: In this study using data from the Osteoarthritis Initiative conducted from 02/2004-10/2015, deep learning-based measurements of knee ESV were derived from baseline and 48-month follow-up knee MRI (n = 2469). OA outcomes included change of Kellgren-Lawrence (KL) grade, Whole-Organ Magnetic Resonance Imaging Score (WORMS) and its subscales (meniscus, bone marrow edema-like lesions [BMELL], cartilage), and symptom progression by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Associations of ESV change (ΔESV) with OA outcome changes were evaluated using spline-based regression models. Effect sizes were reported as interdecile differences (IDDs; 90th vs 10th percentile of the exposure). To compare the associations between ΔESV and ΔMOAKS, differences in IDD (ΔIDD) were estimated. Results: ΔESV was significantly associated with ΔKL grade, ΔWORMS Conclusions: Longitudinal change in ESV was associated with concurrent imaging-based and symptomatic osteoarthritis progression over 48 months. Compared with changes in MOAKS scores, ΔESV showed stronger associations with imaging-based OA outcomes. These findings underscore the potential of MRI-based ΔESV as an osteoarthritis imaging biomarker, while further studies are needed to establish its predictive and clinical utility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.